stierli.com
Stierli IR - Clients
http://www.stierli.com/clients.html
What our clients say. Michael Moore, Vice President, TMX Equicom. We have worked with Julia on several occasions in various European cities. Organization of investor events was always perfect from a professional point of view plus her very personal and individualized touch. This made the events stand out from the usual run of the mill meetings. All communications are timely and prompt. You are always given that feeling of being her very special and most important client.". Martin Rogers, CEO. Julia Stier...
ridgegroup.com
What We Know & Do | The Ridge Group
http://www.ridgegroup.com/areas-of-expertise
Helping you grow your business. What We Know & Do. What We Know & Do. Hands-on experience finding solutions that can propel your organization. In 1996 we formed The Ridge Group to respond to a need for hands-on, practical consulting in the then emerging field of web publishing. Since that time, the internet has grown from an “add-on” to the primary way many companies and their customers conduct business, whether that is by computer, tablet or phone. Specifically, we have demonstrated expertise in:. Lotus...
biotechstocks.com
List of Biotech Stocks - Biotech Stocks | Biotechnology Investments and News. The Future of Innovation & Discovery.
http://biotechstocks.com/content/list-biotech-stocks
List of Biotech Stocks. Trends & Articles. Saturday, August 20, 2016. Welcome to Biotech Stocks. List of Biotech Stocks. Trends & Articles. List of Biotech Stocks. List of Biotech Stocks. Following is a list of companies who have made our radar at Biotech Stocks. At one time or another. This is not a comprehensive list and should be used only as a starting point for your own research. Novice investors or those unfamiliar with Penny Stocks should read our welcome page. Tel Aviv, 6423902. Israel – Map.
screentradingfutures.wordpress.com
ADXS-ADVAXIS « screentradingfutures
https://screentradingfutures.wordpress.com/adxs
There is only one side to the stock market;….not the bull side or the bear side, but the right side. -Jesse Livermore. That’s almost TWO serious side effects PER PATIENT. Advaxis has had 1 in 89 patients! That equates to .01 side effects PER PATIENT! Additionally. do you think cancer patients in India and Africa will be getting $100,000 cancer treatments? This could one day be worth $14! This kind of opportunity cost comes around once in a lifetime! Is a biotechnology company developing the next generati...
bionj.org
Member Directory | BioNJ
http://bionj.org/member-directory
Because Patients Can't Wait℠. Diagnostics and Precision Medicine Committee. Legal, Compliance and Regulatory Committee. BioNJ and New Jersey. Emerging Company in the Spotlight. Chugai Pharma USA, Inc. Purchasing & Talent. The Academy at BioNJ. 4th Annual CEO Summit. 2015 Inspiring Women in STEM Conference Photo Gallery. 2015 CEO Summit Photo Gallery. 2016 BioNJ Annual Dinner Meeting Photo Gallery. Advocacy & Public Policy. BioNJ Public Policy Committee. BioNJ Public Policy Program Support Series. Berkley...
investor-ideas.blogspot.com
Investor Ideas, Trading Ideas and Stocks to Watch : February 2015
http://investor-ideas.blogspot.com/2015_02_01_archive.html
Investor Ideas, Trading Ideas and Stocks to Watch. Investor Ideas, news alerts, trading ideas and commentary from www.Investorideas.com- TSX, NASDAQ, NYSE. Investorideas.com newswire, news and commentary for leading sectors. Wednesday, February 25, 2015. Solar Stock First Solar (FSLR) Gains Following Earnings Report. Solar Stock First Solar (FSLR) Gains Following Earnings Report. 8226; Net sales of $1.0 billion for the fourth quarter and $3.4 billion for 2014. First Solar is a leading global provider of ...
advaxisnewsandresearch.blogspot.com
Advaxis News and Research: May 2010
http://advaxisnewsandresearch.blogspot.com/2010_05_01_archive.html
Advaxis News and Research. An informative site for investors to view news of current and past events about the bio-med company Advaxis . Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria monocytogenes (Lm) cancer vaccines based on technology developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis’ scientific advisory board. Advaxis is developing attenuated live Lm. Tuesday, May 18, 2010. Tuesday, May 18, 2010.
ir.advaxis.com
Press Releases :: Advaxis, Inc. (ADXS)
http://ir.advaxis.com/press-releases/detail/744/advaxis-and-merck-form-collaboration-to-evaluate-investigational-combination-of-two-novel-immunotherapy-candidates-for-advanced-prostate-cancer
Advaxis and Merck Form Collaboration to Evaluate Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer. August 25, 2014. PRINCETON, N.J., Aug. 25, 2014 (GLOBE NEWSWIRE) - Advaxis, Inc. Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration agreement with Merck, known as MSD outside the United States and Canada, through its subsidiaries, to evaluate the combination of Advaxis's Lm.
advaxisnewsandresearch.blogspot.com
Advaxis News and Research
http://advaxisnewsandresearch.blogspot.com/2012/06/video-advaxis-recieves-2012-vie-award.html
Advaxis News and Research. An informative site for investors to view news of current and past events about the bio-med company Advaxis . Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria monocytogenes (Lm) cancer vaccines based on technology developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis’ scientific advisory board. Advaxis is developing attenuated live Lm. Saturday, June 23, 2012. Google Finance - ADXS.
SOCIAL ENGAGEMENT